Age and gender effects on the extent of myocardial involvement in acute myocarditis: A cardiovascular magnetic resonance study

Heart

Volumn 95, Issue 23, 2009, Pages 1925-1930

  Cocker, M S ^a   Abdel Aty, H ^a   Strohm, O ^a   Friedrich, M G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HUMAN; IMAGE QUALITY; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; EDEMA, CARDIAC; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; SEX FACTORS;

EID: 72049100373     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.164061     Document Type: Article

References (25)

1. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
2. Caforio AL, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007;28:1326-33.
3. Kyto V, Saraste A, Voipio-Pulkki LM, et al. Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol 2007;165:570-4.
4. Diaz FJ, Loewe C, Jackson A. Death caused by myocarditis in Wayne County, Michigan: a 9-year retrospective study. Am J Forensic Med Pathol 2006;27:300-3.
5. Skouri HN, Dec GW, Friedrich MG, et al. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006;48:2085-93.
6. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22.
7. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
8. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-9.
9. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
10. Wagner A, Schulz-Menger J, Dietz R, et al. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. Magma 2003;16:17-20.
11. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8.
12. Morimoto S, Kato S, Hiramitsu S, et al. Role of myocardial interstitial edema in conduction disturbances in acute myocarditis. Heart Vessels 2006;21:356-60.
13. Bondarenko O, Beek AM, Hofman MB, et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-5.
14. Hori H, Matoba T, Shingu M, et al. The role of cell mediated immunity in coxsackie B viral myocarditis. Jpn Circ J 1981;45:1409-14.
15. Calder BD, Warnock PJ, McCartney RA, et al. Coxsackie B viruses and the postviral syndrome: a prospective study in general practice. J R Coll Gen Pract 1987;37:11-14.
16. Beck MA, Chapman NM, McManus BM, et al. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 1990;136:669-81.
17. Takata S, Nakamura H, Umemoto S, et al. Identification of autoantibodies with the corresponding antigen for repetitive coxsackievirus infection-induced cardiomyopathy. Circ J 2004;68:677-82.
18. Huber SA, Kupperman J, Newell MK. Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in mice. J Virol 1999;73:4689-95.
19. Frisancho-Kiss S, Nyland JF, Davis SE, et al. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res 2006;1126:139-47.
20. Matsuura H, Palacios IF, Dec GW, et al. Intraventricular conduction abnormalities in patients with clinically suspected myocarditis are associated with myocardial necrosis. Am Heart J 1994;127:1290-7.
21. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:2414-21.
22. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
23. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061-8.
24. Wu LA, Lapeyre AC III, Cooper LT. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc 2001;76:1030-8.
25. Noutsias M, Kuehl U, Lassner D, et al. Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging. Circulation 2007;115:e378-80.